Study of Tecemotide (L-BLP25) in Subjects With Slowly Progressive Multiple Myeloma With no Symptoms and Who Have Had no Chemotherapy
Clinical trial NCT01094548 · COMPLETED
Trial details
- NCT number
- NCT01094548
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2011-02-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.